Company MediciNova, Inc.

Equities

MNOV

US58468P2065

Biotechnology & Medical Research

Market Closed - Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
1.45 USD -1.36% Intraday chart for MediciNova, Inc. +5.07% -3.33%

Business Summary

MediciNova, Inc. is a biopharmaceutical company. The Company is focused on developing therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States market. It is focused on its development activities on MN-166 (ibudilast) for neurological and other disorders, such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, substance dependence and addiction (e.g., methamphetamine dependence, opioid dependence, and alcohol dependence), prevention of acute respiratory distress syndrome (ARDS), and Long COVID, and MN-001 (tipelukast) for fibrotic and other diseases, such as nonalcoholic fatty liver disease (NAFLD) and idiopathic pulmonary fibrosis (IPF). The Company's pipeline also includes MN-221 (bedoradrine) for the treatment of acute exacerbation of asthma and MN-029 (denibulin) for solid tumor cancers.

Number of employees: 13

Sales per Business

USD in Million2022Weight2023Weight Delta
Small Molecule Therapeutics
100.0 %
0 nan % 1 100.0 % -

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
0 nan % 1 100.0 % -

Managers

Managers TitleAgeSince
Founder 74 00-09-25
Director of Finance/CFO 47 22-06-15
Chief Tech/Sci/R&D Officer 58 09-12-31
Investor Relations Contact 55 09-05-31
Corporate Officer/Principal 59 21-04-30

Members of the board

Members of the board TitleAgeSince
Director/Board Member 67 04-08-31
Founder 74 00-09-25
Director/Board Member 66 20-10-19
Chief Tech/Sci/R&D Officer 58 09-12-31
Director/Board Member 49 23-08-03

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 49,046,246 47,790,540 ( 97.44 %) 0 97.44 %

Shareholders

NameEquities%Valuation
3D Investment Partners Pte Ltd.
11.22 %
5,502,047 11.22 % 7 M $
Essex Woodlands Management, Inc.
2.255 %
1,105,941 2.255 % 1 M $
1,091,933 2.226 % 1 M $
BlackRock Institutional Trust Co. NA
1.409 %
691,005 1.409 % 932 857 $
Vanguard Global Advisers LLC
1.271 %
623,333 1.271 % 841 500 $
Citigroup Global Markets, Inc. (Investment Management)
0.9133 %
447,957 0.9133 % 604 742 $
Geode Capital Management LLC
0.8884 %
435,733 0.8884 % 588 240 $
322,996 0.6586 % 436 045 $
Renaissance Technologies LLC
0.3550 %
174,100 0.3550 % 235 035 $
Merrill Lynch International
0.3425 %
167,959 0.3425 % 226 745 $

Company contact information

MediciNova, Inc.

4275 Executive Square Suite 300

92037, La Jolla

+

http://www.medicinova.com
address MediciNova, Inc.(MNOV)